Results 41 to 50 of about 31,420 (68)

Personalized treatment for advanced colorectal cancer: KRAS and beyond

open access: yes, 2013
Gargi Surendra Patel,1 Christos S Karapetis,1,2 1Department of Medical Oncology, Flinders Medical Centre, 2Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, Adelaide, SA, Australia Abstract: Targeted therapies have improved the
Karapetis CS, Patel GS
core  

Utjecaj vremena osvjetljavanja analognih tiskovnih formi na kontaktni kut

open access: yes, 2008
Cilj ovog završnog rada bio je utvrditi ovisnost između kontaktnog kuta močenja monometalne tiskovne forme s diazo slojem i vremenu osvjetljavanja. Močenje je pojava koja se događa pri dodiru dviju različitih faza, obično tekućine i krutine.
Žitinski Elias, Paula Yadranka
core  

Adagrasib in the Treatment of KRAS p.G12C Positive Advanced NSCLC: Design, Development and Place in Therapy [PDF]

open access: yes
Brian Warnecke,1 Misako Nagasaka1,2 1Department of Medicine, University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA; 2Department of Medicine, St.
Nagasaka M, Warnecke B
core  

KRAS Gene Mutation Associated with Grade of Tumor Budding and Peripheral Immunoinflammatory Indices in Patients with Colorectal Cancer [PDF]

open access: yes
Liu Liang,1 Xuemin Guo,1 Wei Ye,1 Yuxiang Liu2 1Department of Laboratory Medicine, Meizhou People’s Hospital, Meizhou, People’s Republic of China; 2Department of Medical Oncology, Meizhou People’s Hospital, Meizhou, People’s Republic of ...
Liu Y, Guo X, Liang L, Ye W
core  

The impact of KRAS mutations on the tumour microenvironment and treatment response in non-small cell lung cancer

open access: yes
Mutations in the KRAS gene in non-small cell lung cancer (NSCLC) are common drivers. Gene expression and mutation data of NSCLC were collected from the TCGA dataset.
Chunling Liu   +5 more
core   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Home - About - Disclaimer - Privacy